These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. Kim CK; Alavi JB; Alavi A; Reivich M J Neurooncol; 1991 Feb; 10(1):85-91. PubMed ID: 2022975 [TBL] [Abstract][Full Text] [Related]
24. FDG-PET screening for cerebral metastases in patients with suspected malignancy. Larcos G; Maisey MN Nucl Med Commun; 1996 Mar; 17(3):197-8. PubMed ID: 8692485 [TBL] [Abstract][Full Text] [Related]
25. Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma. Albano D; Bertoli M; Battistotti M; Rodella C; Statuto M; Giubbini R; Bertagna F Ann Nucl Med; 2018 Oct; 32(8):532-541. PubMed ID: 29982990 [TBL] [Abstract][Full Text] [Related]
26. The utility of 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanoma. Macapinlac HA Mol Imaging Biol; 2004; 6(4):200-7. PubMed ID: 15262235 [TBL] [Abstract][Full Text] [Related]
27. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808 [TBL] [Abstract][Full Text] [Related]
28. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450 [TBL] [Abstract][Full Text] [Related]
30. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. Leskinen-Kallio S; Ruotsalainen U; Någren K; Teräs M; Joensuu H J Nucl Med; 1991 Jun; 32(6):1211-8. PubMed ID: 2045935 [TBL] [Abstract][Full Text] [Related]
32. PET for diagnosis of malignant lymphoma of the scalp: comparison of [11C]methyl-L-methionine and [18F]fluoro-2-deoxyglucose. Tsuyuguchi N; Hakuba A; Okamura T; Ochi H; Suzuki T; Sunada I J Comput Assist Tomogr; 1997; 21(4):590-3. PubMed ID: 9216763 [TBL] [Abstract][Full Text] [Related]
33. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome. Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111 [TBL] [Abstract][Full Text] [Related]
34. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. Schifter T; Hoffman JM; Hanson MW; Boyko OB; Beam C; Paine S; Schold SC; Burger PC; Coleman RE J Comput Assist Tomogr; 1993; 17(4):509-61. PubMed ID: 8392523 [TBL] [Abstract][Full Text] [Related]
35. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644 [TBL] [Abstract][Full Text] [Related]
36. [Cancer screening with whole-body FDG PET]. Yasuda S; Ide M; Takagi S; Shohtsu A Kaku Igaku; 1996 Oct; 33(10):1065-71. PubMed ID: 8952258 [TBL] [Abstract][Full Text] [Related]
37. Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET. Roelcke U; Radü EW; von Ammon K; Hausmann O; Maguire RP; Leenders KL J Neurol Sci; 1995 Sep; 132(1):20-7. PubMed ID: 8523026 [TBL] [Abstract][Full Text] [Related]
38. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma. Delbeke D J Nucl Med; 1999 Apr; 40(4):591-603. PubMed ID: 10210218 [TBL] [Abstract][Full Text] [Related]
39. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. Friedland RP; Budinger TF; Ganz E; Yano Y; Mathis CA; Koss B; Ober BA; Huesman RH; Derenzo SE J Comput Assist Tomogr; 1983 Aug; 7(4):590-8. PubMed ID: 6602819 [TBL] [Abstract][Full Text] [Related]
40. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. Hoh CK; Hawkins RA; Glaspy JA; Dahlbom M; Tse NY; Hoffman EJ; Schiepers C; Choi Y; Rege S; Nitzsche E J Comput Assist Tomogr; 1993; 17(4):582-9. PubMed ID: 8331230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]